If Immunity Is Innate, What Impacts Our Ability to Fight Infections?
Balyn Zaro’s lab investigates the cause and consequence of genetic diversity in the immune system, in hopes that her discoveries can lead to better treatments for all patients.
University of California San Francisco
Give to UCSFBalyn Zaro’s lab investigates the cause and consequence of genetic diversity in the immune system, in hopes that her discoveries can lead to better treatments for all patients.
UCSF experts share insights and tips on supporting children with ADHD amidst a shortage of Adderall and other ADHD medications.
UCSF experts discuss the current state of Alzheimer’s treatments and future therapies that may slow progression of the disease.
Groundbreaking research by UCSF scientists has led to FDA approval of a new therapy that can delay the onset of type 1 diabetes by at least 2 years.
New records in the Opioid Industry Documents show that Insys Therapeutics improperly sold vast amounts of its addictive product for off-label uses.
38 UCSF researchers rank in the top 1 percent for impact in their fields, according to a new analysis of research citations by science and intellectual property company Clarivate.
Nevan Krogan, PhD, director of UC San Francisco’s (UCSF) Quantitative Biosciences Institute (QBI) and founder of QBI’s Coronavirus Research Group (QCRG), has been awarded the Legion of Honor, France’s highest honor, in a ceremony in Paris.
Nevan Krogan, PhD, director UCSF’s Quantitative Biosciences Institute (QBI) and founder of QBI’s Coronavirus Research Group (QCRG), has been awarded the Legion of Honor, France’s highest honor, in a ceremony in Paris.
Scientists at UCSF have developed a new way of looking at sex-biased diseases that is rooted in evolutionary biology.
A new UCSF study researchers of more than 23 million people concludes that some commonly used and abused drugs pose previously unidentified risks for the development of atrial fibrillation (AF), a potentially deadly heart-rhythm disorder.
A small molecule called ISRIB that was identified at UCSF can reverse the neuronal and cognitive effects of concussion in mice weeks after an injury occurred, new research found.